These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 20960111

  • 1. Co-morbidities, management and clinical outcome of auto-immune Addison's disease.
    Leelarathna L, Breen L, Powrie JK, Thomas SM, Guzder R, McGowan B, Carroll PV.
    Endocrine; 2010 Aug; 38(1):113-7. PubMed ID: 20960111
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density in patients with treated Addison's disease.
    Braatvedt GD, Joyce M, Evans M, Clearwater J, Reid IR.
    Osteoporos Int; 1999 Aug; 10(6):435-40. PubMed ID: 10663342
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of corticosteroid replacement therapy and its effect on bones in Addison's disease].
    Heureux F, Maiter D, Boutsen Y, Devogelaer JP, Jamart J, Donckier J.
    Ann Endocrinol (Paris); 2000 Sep; 61(3):179-83. PubMed ID: 10970940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and Immunological Characteristics of Autoimmune Addison Disease: A Nationwide Swedish Multicenter Study.
    Dalin F, Nordling Eriksson G, Dahlqvist P, Hallgren Å, Wahlberg J, Ekwall O, Söderberg S, Rönnelid J, Olcén P, Winqvist O, Catrina SB, Kriström B, Laudius M, Isaksson M, Halldin Stenlid M, Gustafsson J, Gebre-Medhin G, Björnsdottir S, Janson A, Åkerman AK, Åman J, Duchen K, Bergthorsdottir R, Johannsson G, Lindskog E, Landin-Olsson M, Elfving M, Waldenström E, Hulting AL, Kämpe O, Bensing S.
    J Clin Endocrinol Metab; 2017 Feb 01; 102(2):379-389. PubMed ID: 27870550
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of bone mineral density in Addison's disease.
    Jódar E, Valdepeñas MP, Martinez G, Jara A, Hawkins F.
    Clin Endocrinol (Oxf); 2003 May 01; 58(5):617-20. PubMed ID: 12699444
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
    Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES.
    Eur J Endocrinol; 2009 Jun 01; 160(6):993-1002. PubMed ID: 19282465
    [Abstract] [Full Text] [Related]

  • 9. Primary adrenal insufficiency in the United States: diagnostic error and patient satisfaction with treatment.
    Regan EA, Vaidya A, Margulies PL, Make BJ, Lowe KE, Crapo JD.
    Diagnosis (Berl); 2019 Nov 26; 6(4):343-350. PubMed ID: 31256064
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR, Ventz M, Diederich S, Quinkler M.
    J Clin Endocrinol Metab; 2012 Jan 26; 97(1):85-92. PubMed ID: 21994966
    [Abstract] [Full Text] [Related]

  • 11. Autoimmune Addison's disease - An update on pathogenesis.
    Hellesen A, Bratland E, Husebye ES.
    Ann Endocrinol (Paris); 2018 Jun 26; 79(3):157-163. PubMed ID: 29631795
    [Abstract] [Full Text] [Related]

  • 12. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid.
    Chikada N, Imaki T, Hotta M, Sato K, Takano K.
    Endocr J; 2004 Jun 26; 51(3):355-60. PubMed ID: 15256782
    [Abstract] [Full Text] [Related]

  • 13. [Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].
    Salah DB, Charfi N, Elleuch M, Kacem FH, Rekik N, Mnif M, Mnif F, Abid M.
    Pan Afr Med J; 2018 Jun 26; 30():251. PubMed ID: 30627312
    [Abstract] [Full Text] [Related]

  • 14. Autoimmune Addison's disease.
    Saverino S, Falorni A.
    Best Pract Res Clin Endocrinol Metab; 2020 Jan 26; 34(1):101379. PubMed ID: 32063488
    [Abstract] [Full Text] [Related]

  • 15. Screening for associated autoimmune disorders in Polish patients with Addison's disease.
    Fichna M, Fichna P, Gryczyńska M, Walkowiak J, Zurawek M, Sowiński J.
    Endocrine; 2010 Apr 26; 37(2):349-60. PubMed ID: 20960274
    [Abstract] [Full Text] [Related]

  • 16. Reversible hypothyroidism after steroid replacement for Addison's disease.
    Burrows AW.
    Postgrad Med J; 1981 Jun 26; 57(668):368-70. PubMed ID: 7301682
    [Abstract] [Full Text] [Related]

  • 17. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M, Gryczyńska M, Sowińska A, Sowiński J.
    Przegl Lek; 2011 Jun 26; 68(2):96-102. PubMed ID: 21751518
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution.
    Fichna M, Zurawek M, Fichna P, Gryczynska M, Nowak J, Ruchala M.
    J Physiol Pharmacol; 2012 Dec 26; 63(6):677-82. PubMed ID: 23388484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.